Profile: Biocompatibles International Plc (BII.L)

Biocompatibles International plc is a medical technology company focused on drug device Combination Products for use in oncology. The Company operates through an Oncology Products Division and two research and development (R&D) businesses. During the year ended December 31, 2008, the Company’s International Division changed to Oncology Products. The Oncology Products Division conducts the marketing of the Company’s approved oncology products. These include Drug-Eluting Bead products, which are used in more than 35 countries for the treatment of primary liver cancer (HCC), liver metastases from colo-rectal cancer, and other cancers, and Brachytherapy products (radiation-delivering seeds), which are used in the treatment of prostate cancer. Some of its Bead Products include Bead Block, LC Bead, DC Bead and PRECISION Bead. Its R&D Facilities are engaged in licensing and in new product development, based on the Company’s core drug delivery technologies.